Acute myocardial infarction secondary to mucormycosis after lung transplantation

Chetan A Naik; Susan K Mathai; Uriel S Sandkovsky; Kenneth A Ausloos; Joseph M Guileyardo; Gary Schwartz; David P Mason; Robert Gottlieb; Todd J Grazia

doi:10.1016/j.idcr.2020.e01019

Acute myocardial infarction secondary to mucormycosis after lung transplantation

IDCases. 2020 Dec 9:23:e01019. doi: 10.1016/j.idcr.2020.e01019. eCollection 2021.

Authors

Chetan A Naik¹, Susan K Mathai¹, Uriel S Sandkovsky², Kenneth A Ausloos¹, Joseph M Guileyardo³, Gary Schwartz⁴, David P Mason⁴, Robert Gottlieb⁵, Todd J Grazia¹

Affiliations

¹ Center for Advanced Heart & Lung Diseases, Division of Pulmonary and Critical Care Medicine, Baylor University Medical Center at Dallas, Dallas, TX, USA.
² Division of Infectious Diseases, Baylor University Medical Center at Dallas, Dallas, TX, USA.
³ Department of Pathology, Baylor University Medical Center at Dallas, Dallas, TX, USA.
⁴ Department of Surgery, Thoracic Surgery, Baylor University Medical Center at Dallas, Dallas, TX, USA.
⁵ Center for Advanced Heart & Lung Diseases, Division of Cardiology, Baylor University Medical Center at Dallas, Dallas, TX, USA.

Abstract

We present a case of a 57-year-old man who underwent bilateral lung transplantation for idiopathic pulmonary fibrosis. His immediately post-operative course was complicated by fever and cardiac arrest. Despite supportive care and broad-spectrum antibiotics, he experienced continued clinical decline. Autopsy results indicated angioinvasive mucormycosis and coronary arteritis resulting in acute myocardial infarction as the cause of death.

Keywords: Idiopathic pulmonary fibrosis; Lung transplantation; Mucormycosis.

Publication types

Case Reports